Usefulness of endoscopic ultrasound‐guided sampling using core biopsy needle as a percutaneous biopsy rescue for diagnosis of solid liver mass: Combined histological‐cytological analysis

Lee, Yun Nah; Moon, Jong Ho; Kim, Hee Kyung; Choi, Moon Han; Kim, Dong Choon; Lee, Tae Hee; Lee, Tae Hoon; Cha, Sang‐Woo; Kim, Sang Gyune; Kim, Young Seok

doi:10.1111/jgh.12922

Cited by 48 publications

(41 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, fewer passes were required to obtain the pathological diagnosis in the core biopsy needle group (1.0 vs 2.0). Lee et al also reported the usefulness of EUS‐guided sampling for solid liver masses by using core biopsy needle . We had expanded the study to evaluate molecular test from EUS‐guided samples for liver masses.…”

Section: Discussionmentioning

confidence: 99%

“…Lee et al also reported the usefulness of EUS-guided sampling for solid liver masses by using core biopsy needle. 22 We had expanded the study to evaluate molecular test from EUS-guided samples for liver masses. In this study, the core biopsy needle was used with the expectation of obtaining sufficient samples for cytohistology and KRAS mutation analysis.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

KRAS mutation analysis by next‐generation sequencing in endoscopic ultrasound‐guided sampling for solid liver masses

Choi

Kim

Lee

et al. 2017

J of Gastro and Hepatol

Self Cite

View full text Add to dashboard Cite

EUS-guided tissue sampling for solid liver masses in the left lobe provided high diagnostic accuracy from cytological and histological evaluations. KRAS mutation analysis provided additional diagnostic yield in patients with inconclusive cytohistopathological results from EUS-guided tissue sampling. The NGS method detected additional KRAS mutations in patients with negative PNA-mediated PCR clamping test results.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

KRAS mutation analysis by next‐generation sequencing in endoscopic ultrasound‐guided sampling for solid liver masses

Choi

Kim

Lee

et al. 2017

J of Gastro and Hepatol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Cytological diagnoses were classified as positive for malignancy, suspicious for malignancy, atypical, negative, and inadequate. [9] Cytological diagnoses classified as positive for malignancy and suspicious for malignancy were considered malignant. [10] Cytological examination that was diagnostic for malignancy was considered the definitive diagnosis.…”

Section: Methodsmentioning

confidence: 99%

Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass

Seo

Hong

et al. 2017

Endosc Ultrasound

View full text Add to dashboard Cite

Background and Objectives:Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has been established as a safe and accurate method for diagnosing and staging intra-abdominal mass. However, few studies investigated its feasibility, efficacy, and safety for targeting liver mass. We evaluated the efficacy and safety of EUS-FNA in patients with liver masses including the right lobe.Patients and Methods:The technical feasibility, safety, and diagnostic yield were determined in 47 patients (30 in the left lobe and 17 in the right lobe) presenting with liver masses between September 2010 and February 2016.Results:Thirty-eight patients (80.9%) had malignancies whereas nine patients (19.1%) had benign liver masses. Technical success rate was 97.9% (46/47). EUS-FNA was diagnostic in 38 of 42 patients (90.5%). When the outcomes of EUS-FNA between right liver mass and left mass were accessed, the technical success rates were similar in both lobes (100% vs. 94.1%, P = 0.2). The median tumor size on EUS (25.5 mm, interquartile range [IQR] 13.8–30.3 vs. 28 mm, IQR 18.5–43.5, P = 0.24) and number of needle passes (3, IQR 3–4 vs. 3, IQR 3–3, P = 0.24) were not significantly different. Adequate specimen obtained was statistically higher in the left lobe (28/30, 93.3% vs. 14/17, 82.4%, P = 0.04). However, diagnostic accuracy for liver masses was not different (25/28, 89.3% vs. 13/14, 92.9%, P = 0.86). No complications developed after procedure.Conclusions:EUS-FNA can be a safe and efficient method for the diagnosis of liver mass and it is technically feasible even for those in the right lobe.

show abstract

“…In these cases, EUS biopsies are preferable. 216 Transvenous biopsies from the internal jugular vein through the vena cava are reserved for lesions adjacent to the venous system or where there is significant bleeding risk or ascites. 217 Similarly, FNAB, CNB, and occasionally microforceps 218 modes are used depending on the application.…”

Section: Livermentioning

confidence: 99%

Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care

Pritzker

Nieminen

2019

Archives of Pathology &Amp; Laboratory Medicine

View full text Add to dashboard Cite

Context.— Needle biopsy of diseased tissue is an essential diagnostic tool that is becoming even more important as precision medicine develops. However, the capability of this modality to efficiently provide samples adequate for diagnostic and prognostic analysis remains quite limited relative to current diagnostic needs. For physicians and patients, inadequate biopsy frequently leads to diagnostic delay, procedure duplication, or insufficient information about tumor biology leading to delay in treatment; for health systems, this results in substantial incremental costs and inefficient use of scarce specialized diagnostic resources. Objective.— To review current needle biopsy technology, devices, and practice with a perspective to identify current limitations and opportunities for improvement in the context of advancing precision medicine. Data Sources.— PubMed searches of fine-needle aspiration and core needle biopsy devices and similar technologies were made generally, by tissue site, and by adequacy as well as by health economics of these technologies. Conclusions.— Needle biopsy adequacy can be improved by recognizing the importance of this diagnostic tool by promoting common criteria for needle biopsy adequacy; by optimizing needle biopsy procedural technique, technologies, clinical practice, professional education, and quality assurance; and by bundling biopsy procedure costs with downstream diagnostic modalities to provide better accountability and incentives to improve the diagnostic process.

show abstract

Usefulness of endoscopic ultrasound‐guided sampling using core biopsy needle as a percutaneous biopsy rescue for diagnosis of solid liver mass: Combined histological‐cytological analysis

Abstract: EUS-FNB with core biopsy needle for solid liver mass may be helpful in the management of patients who are unable to diagnose using percutaneous liver biopsy.

Cited by 48 publications

References 21 publications

KRAS mutation analysis by next‐generation sequencing in endoscopic ultrasound‐guided sampling for solid liver masses

KRAS mutation analysis by next‐generation sequencing in endoscopic ultrasound‐guided sampling for solid liver masses

Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass

Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care

Contact Info

Product

Resources

About